Akamine Scott 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Jun 3, 2021
Insider Transaction Report
Form 4
Akamine Scott
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-01+281,762→ 281,762 totalExercise: $13.17Exp: 2031-06-01→ Common Stock (281,762 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on June 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.